These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20386870)

  • 1. Early increase of plasma homocysteine in sepsis patients with poor outcome.
    Ploder M; Kurz K; Spittler A; Neurauter G; Roth E; Fuchs D
    Mol Med; 2010; 16(11-12):498-504. PubMed ID: 20386870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-alpha.
    Frick B; Capuron L; Schröcksnadel K; Musselman DL; Lawson DH; Nemeroff CB; Miller AH; Fuchs D
    J Interferon Cytokine Res; 2004 May; 24(5):311-7. PubMed ID: 15153315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated tryptophan degradation predicts poor survival in trauma and sepsis patients.
    Ploder M; Spittler A; Kurz K; Neurauter G; Pelinka LE; Roth E; Fuchs D
    Int J Tryptophan Res; 2010; 3():61-7. PubMed ID: 22084588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinaemia and immune activation in patients with cancer.
    Schroecksnadel K; Frick B; Fiegl M; Winkler C; Denz HA; Fuchs D
    Clin Chem Lab Med; 2007; 45(1):47-53. PubMed ID: 17243914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia and immune activation.
    Schroecksnadel K; Frick B; Winkler C; Leblhuber F; Wirleitner B; Fuchs D
    Clin Chem Lab Med; 2003 Nov; 41(11):1438-43. PubMed ID: 14656023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.
    Ploder M; Spittler A; Schroecksnadel K; Neurauter G; Pelinka LE; Roth E; Fuchs D
    Clin Sci (Lond); 2009 Apr; 116(7):593-8. PubMed ID: 18986303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease.
    Widner B; Leblhuber F; Frick B; Laich A; Artner-Dworzak E; Fuchs D
    J Neural Transm (Vienna); 2002 Dec; 109(12):1445-52. PubMed ID: 12486485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neopterin levels and Kyn/Trp ratios were significantly increased in dengue virus patients and subsequently decreased after recovery.
    Geisler S; Lytton SD; Toan NL; Nghia TH; Nam NM; Hung HV; Son NT; Anh DT; Tuyen HT; Tien TV; Quyet D; Van Tong H; Hoan NX; Song LH; Pallerla SR; Gostner JM; Fuchs D; Velavan TP
    Int J Infect Dis; 2020 Feb; 91():162-168. PubMed ID: 31821895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age.
    Frick B; Schroecksnadel K; Neurauter G; Leblhuber F; Fuchs D
    Clin Biochem; 2004 Aug; 37(8):684-7. PubMed ID: 15302611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between homocysteine and neopterin concentrations in patients with gynecological cancer.
    Schroecksnadel K; Frick B; Winkler C; Fuith LC; Fuchs D
    Cancer Lett; 2006 Aug; 240(2):198-202. PubMed ID: 16271434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of tryptophan load test followed by serum kynurenine determination. Its comparison with pyridoxal-5-phosphate, kynurenine, homocysteine and neopterin amounts.
    Rudzite V; Fuchs D; Kalnins U; Jurika E; Silava A; Erglis A; Trusinskis K; Jegere S
    Adv Exp Med Biol; 2003; 527():307-15. PubMed ID: 15206744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study of tryptophan degradation during and after pregnancy.
    Schröcksnadel K; Widner B; Bergant A; Neurauter G; Schennach H; Schröcksnadel H; Fuchs D
    Life Sci; 2003 Jan; 72(7):785-93. PubMed ID: 12479977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced degradation of tryptophan in patients on hemodialysis.
    Koenig P; Nagl C; Neurauter G; Schennach H; Brandacher G; Fuchs D
    Clin Nephrol; 2010 Dec; 74(6):465-70. PubMed ID: 21084050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between plasma thiols and immune activation marker neopterin in stable coronary heart disease.
    Schroecksnadel K; Walter RB; Weiss G; Mark M; Reinhart WH; Fuchs D
    Clin Chem Lab Med; 2008; 46(5):648-54. PubMed ID: 18839466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.
    Gostner JM; Obermayr E; Braicu IE; Concin N; Mahner S; Vanderstichele A; Sehouli J; Vergote I; Fuchs D; Zeillinger R
    Gynecol Oncol; 2018 May; 149(2):371-380. PubMed ID: 29530331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?
    Fuchs D; Jaeger M; Widner B; Wirleitner B; Artner-Dworzak E; Leblhuber F
    Clin Chem Lab Med; 2001 Aug; 39(8):691-4. PubMed ID: 11592434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hyperhomocysteinemia in Alzheimer disease with elevated neopterin levels.
    Schroecksnadel K; Leblhuber F; Frick B; Wirleitner B; Fuchs D
    Alzheimer Dis Assoc Disord; 2004; 18(3):129-33. PubMed ID: 15494618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neopterin as an Effect Modifier of the Cardiovascular Risk Predicted by Total Homocysteine: A Prospective 2-Cohort Study.
    Bjørnestad EØ; Borsholm RA; Svingen GFT; Pedersen ER; Seifert R; Midttun Ø; Ueland PM; Tell GS; Bønaa KH; Nygård O
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.
    Widner B; Leblhuber F; Fuchs D
    J Neural Transm (Vienna); 2002 Feb; 109(2):181-9. PubMed ID: 12075858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine and serum markers of immune activation in primary dystonia.
    Muller UJ; Frick B; Winkler C; Fuchs D; Wenning GK; Poewe W; Mueller J
    Mov Disord; 2005 Dec; 20(12):1663-7. PubMed ID: 16108020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.